Invesco
ORMP icon

Invesco’s Oramed Pharmaceuticals ORMP Stock Holding History

Invesco’s Portfolio ORMP Stock Details ORMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-10,094
Closed -$26.3K – 3881
2023
Q3 		$26.3K Buy
+10,094
New +$31.8K ﹤0.01% 3847
2023
Q2 		– Sell
-13,375
Closed -$29.2K – 3920
2023
Q1 		$29.2K Buy
+13,375
New +$42.5K ﹤0.01% 3790
2022
Q2 		– Sell
-14,370
Closed -$124K – 4116
2022
Q1 		$124K Buy
14,370
+1,379
+11% +$14.1K ﹤0.01% 3849
2021
Q4 		$186K Sell
12,991
-742,204
-98% -$15.5M ﹤0.01% 3800
2021
Q3 		$16.6M Buy
755,195
+743,715
+6,478% +$12.7M ﹤0.01% 1683
2021
Q2 		$154K Buy
+11,480
New +$131K ﹤0.01% 3833

Other funds holding ORMP

BCM
BML Capital Management Zionsville, Indiana $155M AUM 129.82% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $249M AUM 68.08% 1-Year Est. Return
BFM
Boothbay Fund Management New York $4.34B AUM 106.31% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $25B AUM 18.87% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Squarepoint
Squarepoint New York $46.5B AUM 20.93% 1-Year Est. Return